AVLO

Latest SEC Filings & News for AVLO

2 most recent filings and news items mentioning AVLO. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/AVLO/news?limit=20"

Pull AVLO filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

OfferingJun 12, 2026Neutral

Avalo Therapeutics designates Series C-1 non-voting convertible preferred stock

Avalo Therapeutics' board established a new series of preferred stock with an initial stated value of $5,796.93 per share, convertible to common stock. The offering is led by Commodore Capital Master LP and provides the company with additional capital financing options.

View filing at SEC.gov →

OtherJun 8, 2026Neutral

Avalo Therapeutics adopts Second Amended and Restated 2016 Employee Stock Purchase Plan

Avalo Therapeutics' Board of Directors adopted and stockholders approved an amended Employee Stock Purchase Plan on June 2, 2026, allowing eligible employees to purchase company shares. The plan modification reflects standard corporate governance practices for employee compensati

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.